[HTML][HTML] Review on uremic toxins: classification, concentration, and interindividual variability

…, P Stenvinkel, C Tetta, C Wanner, W Zidek… - Kidney international, 2003 - Elsevier
Review on uremic toxins: Classification, concentration, and interindividual variability.
Background The choice of the correct concentration of potential uremic toxins for in vitro, ex vivo, …

Performance of a minimally invasive uncalibrated cardiac output monitoring system (FloTrac™/Vigileo™) in haemodynamically unstable patients

…, B Zukunft, C Hoffmann, W Zidek… - British journal of …, 2008 - academic.oup.com
Background Early haemodynamic assessment is of particular importance in the evaluation
of haemodynamically compromised patients, but is often precluded by the invasiveness and …

Low-grade albuminuria and cardiovascular risk: what is the evidence?

RE Schmieder, J Schrader, W Zidek, U Tebbe… - Clinical Research in …, 2007 - Springer
Microalbuminuria (MA), conventionally defined as a urinary albumin excretion (UAE) of 30–300
mg/day, is recognised as a marker of endothelial dysfunction. Furthermore, it represents …

[HTML][HTML] Prevention of radiographic-contrast-agent–induced reductions in renal function by acetylcysteine

…, U Laufer, D Liermann, W Zidek - … England Journal of …, 2000 - Mass Medical Soc
Background Radiographic contrast agents can cause a reduction in renal function that may
be due to reactive oxygen species. Whether the reduction can be prevented by the …

Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study …

…, F Hammersen, K Plate, J Berger, W Zidek… - Stroke, 2005 - Am Heart Assoc
Background and Purpose— In hypertensive stroke patients, for the same level of blood pressure
control, eprosartan will be more effective than nitrendipine in reducing cerebrovascular …

The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors

…, S Lüders, A Kulschewski, J Berger, W Zidek… - Stroke, 2003 - Am Heart Assoc
Background and Purpose— The Acute Candesartan Cilexetil Therapy in Stroke Survivors (ACCESS)
study was designed to assess the safety of modest blood pressure reduction by …

Aerobic exercise reduces blood pressure in resistant hypertension

F Dimeo, N Pagonas, F Seibert, R Arndt, W Zidek… - …, 2012 - Am Heart Assoc
… In this protocol each workload corresponds with an increase of 25 W for a patient of 75 kg
weight. Assessment of maximal oxygen uptake is the gold standard for the determination of …

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

…, M van der Giet, M Statz, J Jankowski, W Zidek - Circulation, 2003 - Am Heart Assoc
… 4 to 3.5×R)×UF/W, where R is the post/preplasma urea nitrogen ratio; UF is the ultrafiltrate
volume (liters) removed; and W is the postdialysis weight (kg). Mean Kt/V values were 1.4±0.3. …

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure–a prospective …

…, W Zidek, M Böhm, M Middeke, W Motz… - Journal of …, 2008 - journals.lww.com
Zidek contributed towards analysis or interpretation of data, and revision of the manuscript.
… Unger, W. Zidek have given lectures sponsored by Aventis Pharma, and other major …

Validation of the mobil-O-Graph: 24 h-blood pressure measurement device

W Wei, M Tölle, W Zidek… - Blood pressure …, 2010 - journals.lww.com
Objective Twenty-four-hour blood pressure measurement is of importance not only in the
detection of hypertension but also in the detection of blood pressure changes in hypertensive …